Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2005-10-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BBRC.2005.08.082PMID 16139248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis.

  2005cited by this paper
• Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.

  2004cited by this paper
• ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions

  2004cited by this paper
• Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation

  2003cited by this paper
• An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development

  2003cited by this paper
• Essential role for ERK2 mitogen‐activated protein kinase in placental development

  2003cited by this paper
• Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets

  2003cited by this paper
• Mitogen-Activated Protein Kinase Inhibition in Traumatic Brain Injury: In Vitro and In Vivo Effects

  2002cited by this paper
• Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory.

  2002cited by this paper
• Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning.

  2001cited by this paper
• Role of Ras and Mapks in TGFβ signaling

  2000cited by this paper
• Role of Ras and Mapks in TGFbeta signaling.

  2000cited by this paper
• Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts.

  1999cited by this paper
• Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.

  1999cited by this paper
• Structural basis of inhibitor selectivity in MAP kinases.

  1998cited by this paper
• A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase

  1998cited by this paper
• Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription

  1998cited by this paper
• Activity of the MAP kinase ERK2 is controlled by a flexible surface loop.

  1995cited by this paper
• Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution

  1994cited by this paper
• On the computation of the fast rotation function.

  1993cited by this paper

• The KEAP1/NRF2 axis controls LPS-induced oxidative stress, inflammasome activation and caspase-1 activity in human endothelial cells

  2026cites this paper
• A Tetrazine‐Based Synthesis for Accessing Underutilized Aza‐Indole Analogues

  2025cites this paper
• A New 5‐fluoro‐2‐(methylamino)benzenesulfonamide (SA) as a Potential ERK2 Inhibitor: Synthesis, ADMET Analysis, and Anticancer Testing in A549 Lung Cells

  2025cites this paper
• Pharmacologically active constituents of Buyang Huanwu Decoction against cerebral ischemia-reperfusion injury and verification of its effects on oxidative stress, energy metabolism, and inflammation.

  2025cites this paper
• Advances in ERK1/2 inhibition: a medicinal chemistry perspective on structure and regulation

  2025cites this paper
• Neuronal activation in the axolotl brain promotes tail regeneration

  2025cites this paper
• Discovery of Novel Aromatic Urea-Imidazole Salt Derivatives for Cancer Therapy via Targeting ERK1/2.

  2025cites this paper
• Molecular Frameworks for ERK1/2 Inhibition: Lessons from Synthetic and SAR Explorations

  2025cites this paper
• Oncogenic RAS induces a distinctive form of non-canonical autophagy mediated by the P38-ULK1-PI4KB axis

  2025cites this paper
• Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines

  2024cites this paper
• Tetraarylantimony 2,2′-bipyridinecarboxylates: synthesis, photophysical and molecular docking studies

  2024cites this paper
• IL-1β-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial–mesenchymal transition

  2024cites this paper
• The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cells

  2024cites this paper
• A7, A Novel Analog of Curcumin, Induces Cell Apoptosis Through Suppressing TGF-βR/MEK/ERK Pathway in A549 Cells

  2024cites this paper
• AI-based prediction of protein–ligand binding affinity and discovery of potential natural product inhibitors against ERK2

  2024cites this paper
• Ganoderic acid a alleviates Aβ25−35-induced HT22 cell apoptosis through the ERK/MAPK pathway: a system pharmacology and in vitro experimental validation

  2024cites this paper
• pERK transition–induced directional mode switching promotes epithelial tumor cell migration

  2024cites this paper
• A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD).

  2024cites this paper
• Naturally Occurring Plant‐Based Anticancerous Candidates as Potential ERK2 Inhibitors: In‐Silico Database Mining and Molecular Dynamics Simulations

  2024cites this paper
• TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer

  2024cites this paper
• Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells

  2024cites this paper
• Distinct binding modes of a benzothiazole derivative confer structural bases for increasing ERK2 or p38α MAPK selectivity.

  2024cites this paper
• Chlorophyll Derivatives Exert Greater Potency Over Progesterone in the Prevention of Infection‐Induced Preterm Birth in Murine Models

  2024cites this paper
• Network pharmacology and bioinformatic integrative analysis reveals candidate gene targets and potential therapeutic of East Kalimantan propolis against hepatocellular carcinoma

  2024cites this paper
• Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment.

  2024cites this paper
• Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

  2024cites this paper
• TGFβ1-driven SMAD2/3 phosphorylation and myofibroblast emergence are fully dependent on the TGFβ1 pre-activation of MAPKs and controlled by maternal leucine zipper kinase.

  2023cites this paper
• Ouabain’s Influence on TRPV4 Channels of Epithelial Cells: An Exploration of TRPV4 Activity, Expression, and Signaling Pathways

  2023cites this paper
• A novel selective ERK1/2 inhibitor, Laxiflorin B, targets EGFR mutation subtypes in non-small-cell lung cancer

  2023cites this paper
• Navigating the ERK1/2 MAPK Cascade

  2023cites this paper
• Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectives.

  2023cites this paper
• Modified Signaling of Membrane Formyl Peptide Receptors in NADPH-Oxidase Regulation in Obesity-Resistant Mice

  2023cites this paper
• Low entropic cost of binding confers high selectivity on an allosteric ERK2 inhibitor.

  2023cites this paper
• Identification of a novel target site for ATP-independent ERK2 inhibitors.

  2022cites this paper
• Ouabain-Induced Changes in the Expression of Voltage-Gated Potassium Channels in Epithelial Cells Depend on Cell–Cell Contacts

  2022cites this paper
• Current developments in extracellular-regulated protein kinase (ERK1/2) inhibitors.

  2022cites this paper
• Dissecting protein tyrosine phosphatase signaling by engineered chemogenetic control of its activity

  2022cites this paper
• Acridone Derivatives from Atalantia monophyla Inhibited Cancer Cell Proliferation through ERK Pathway

  2022cites this paper
• Peptide‐Based Inhibitors that Target the Docking Site of ERK2

  2022cites this paper
• MAPKs/AP-1, not NF-κB, is responsible for MCP-1 production in TNF-α-activated adipocytes

  2022cites this paper
• Analysis of Spontaneous and Induced Osteogenic Differentiation in 3D-micromasses of Human Multipotent Stem Cells

  2022cites this paper
• Targeted Inhibition of Select ERK1/2 Functions Mitigates Pathological Features of Asthma in Mice.

  2022cites this paper
• Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels.

  2022cites this paper
• RETRACTED ARTICLE: Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection

  2022cites this paper
• A Novel Selective ERK1/2 Inhibitor, Laxiflorin B, Targets EGFR Mutation Subtypes in Non-small-cell Lung Cancer

  2022cites this paper
• Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy

  2022cites this paper
• Mesentery AjFGF4–AjFGFR2–ERK pathway modulates intestinal regeneration via targeting cell cycle in echinoderms

  2022cites this paper
• Future Drug Targets in Periodontal Personalised Medicine—A Narrative Review

  2022cites this paper
• ERK contributes to B cell receptor-induced cell spreading in the A20 mouse B cell line

  2022cites this paper
• Identification of potential extracellular signal-regulated protein kinase 2 inhibitors based on multiple virtual screening strategies

  2022cites this paper
• LPA2 promotes neuronal differentiation and neurite formation in neocortical development.

  2022cites this paper
• Combining Network Pharmacology with Molecular Docking for Mechanistic Research on Thyroid Dysfunction Caused by Polybrominated Diphenyl Ethers and Their Metabolites

  2021influential citation
• MAP kinases in regulation of NOX activity stimulated through two types of formyl peptide receptors in murine bone marrow granulocytes.

  2021cites this paper
• The Effect of Medroxyprogesterone Acetate on the Secretion of Lipoprotein Lipase in Mouse Mammary Tumor Cells

  2021cites this paper
• RAF-MEK-ERK pathway in cancer evolution and treatment.

  2021cites this paper
• Ligase Pellino3 Regulates Macrophage Action and Survival in Response to VSV Infection in RIG-I-Dependent Path

  2021cites this paper
• The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV

  2021cites this paper
• Recent advances in development of hetero-bivalent kinase inhibitors.

  2021cites this paper
• Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells

  2021influential citation
• Increase in Blood-Brain Barrier (BBB) Permeability Is Regulated by MMP3 via the ERK Signaling Pathway

  2021influential citation
• The Effect of Medroxyprogesterone Acetate on the Secretion of Lipoprotein Lipase in Mouse Mammary Tumor Cells

  2021cites this paper
• Continuous Inhibition of Sonic Hedgehog Signaling Leads to Differentiation of Human-Induced Pluripotent Stem Cells into Functional Insulin-Producing β Cells

  2021cites this paper
• DUSP7 regulates the activity of ERK2 to promote proper chromosome alignment during cell division

  2020influential citation
• Enhancement of the antitumor effect of HER2‐directed CAR‐T cells through blocking epithelial‐mesenchymal transition in tumor cells

  2020cites this paper
• Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter

  2020cites this paper
• Continuous inhibition of Sonic hedgehog signaling effectively leads to differentiation of human-induced pluripotent stem cells into functional insulin-producing β cells

  2020cites this paper
• FAK regulates actin polymerization during sperm capacitation via the ERK2/GEF-H1/RhoA signaling pathway

  2020cites this paper
• Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutations

  2020cites this paper
• Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases—Current State of the Art

  2020cites this paper
• Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites

  2020cites this paper
• Blood-brain barrier permeability is regulated by matrix metalloproteinase-3 via the ERK signaling pathway

  2020cites this paper
• Novel Peptide-Based Inhibitors of Protein Kinases

  2020cites this paper
• Design, synthesis, andin vitroanticancer screening of novel pyrazolinyl‐pyrazole/1, 2, 3‐triazole hybrids

  2020cites this paper
• The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2?

  2020cites this paper
• Biochemical, Cellular and Structural Characterization of Novel and Selective ERK3 Inhibitors.

  2020cites this paper
• PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism

  2020cites this paper
• Long-Lasting Activity of ERK Kinase Depends on NFATc1 Induction and Is Involved in Cell Migration-Fusion in Murine Macrophages RAW264.7

  2020cites this paper
• Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer

  2020cites this paper
• Importance of protein flexibility in ranking ERK2 Type I1/2 inhibitor affinities: a computational study

  2019cites this paper
• Comprehensive analysis of a dipeptide library to identify ghrelin release‐modulating peptides

  2019cites this paper
• Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance

  2019cites this paper
• Protein Allostery in Rational Drug Design.

  2019cites this paper
• ERK2 mini-fragment binding

  2019cites this paper
• L-Carnitine Reduces Oxidative Stress and Promotes Cells Differentiation and Bone Matrix Proteins Expression in Human Osteoblast-Like Cells

  2019cites this paper
• Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer

  2019influential citation
• HSV-1/TLR9-Mediated IFNβ and TNFα Induction Is Mal-Dependent in Macrophages

  2019cites this paper
• Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy

  2019cites this paper
• Identification of lead molecules against potential drug target protein MAPK4 from L. donovani: An in-silico approach using docking, molecular dynamics and binding free energy calculation

  2019cites this paper
• Staphylococcal superantigen‐like proteins interact with human MAP kinase signaling protein ERK2

  2019cites this paper
• Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design.

  2019cites this paper
• Inhibition of Oncogenic Kinases: An In Vitro Validated Computational Approach Identified Potential Multi-Target Anticancer Compounds

  2019cites this paper
• Visualizing cellular heterogeneity by quantifying the dynamics of MAPK activity in live mammalian cells with synthetic fluorescent biosensors

  2019cites this paper
• FGF Gradient Controls Boundary Position Between Proliferating and Differentiating Cells and Regulates Lacrimal Gland Growth Dynamics

  2019cites this paper
• Small molecules capable of activating DNA methylation–repressed genes targeted by the p38 mitogen-activated protein kinase pathway

  2018cites this paper
• Muscarinic receptor antagonists activate ERK‐CREB signaling to augment neurite outgrowth of adult sensory neurons

  2018influential citation
• The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance.

  2018influential citation
• ERK1/2 inhibitors: New weapons to inhibit the RAS‐regulated RAF‐MEK1/2‐ERK1/2 pathway

  2018cites this paper
• Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathway

  2018cites this paper
• FGF23 modulates the effects of erythropoietin on gene expression in renal epithelial cells

  2018cites this paper
• Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis

  2018cites this paper